The body & medicine

The kidneys shut down, but nothing is wrong with the kidneys

Hepatorenal syndrome is a form of kidney failure that strikes people whose livers are badly failing, whether from long-standing cirrhosis or a sudden catastrophic liver injury. It isn't caused by direct damage to the kidneys themselves but by a knock-on effect of liver disease: blood vessels supplying the gut widen dramatically, tricking the body into constricting blood flow to the kidneys as if blood volume were too low, and this constriction eventually strangles kidney function. It's often set off by an infection, gastrointestinal bleeding, or overly aggressive use of diuretics or fluid removal in someone already living with cirrhosis. Doctors distinguish a fast-moving type, where creatinine shoots up within weeks and mortality is especially brutal, from a slower type tied to ascites that no longer responds to water pills. Because so many other kidney problems can look similar in someone with liver disease, diagnosis depends on ruling out infection, kidney-toxic drugs, structural kidney damage, and other conditions like acute tubular necrosis, using blood and urine tests rather than any single definitive marker.

Outlook is bleak without a new liver, with short-term death rates in the fast-progressing type historically exceeding half of patients within a month. Liver transplantation is the only real cure, though even then kidney function can dip further afterward, largely because of the kidney-toxic drugs used to prevent organ rejection; recovery is nonetheless the norm, and long-term survival ends up matching that of other transplant recipients. While patients wait for a transplant, treatment centers on shrinking the abnormal blood vessel dilation with drugs such as terlipressin or the combination of midodrine and octreotide, usually paired with intravenous albumin, and sometimes a shunt placed between veins in the liver to relieve pressure. Dialysis, including a specialized albumin-based version, can buy time but doesn't restore kidney function on its own, and its actual benefit remains uncertain. Prevention efforts focus on catching infections and bleeding early, avoiding overly aggressive diuretic use, and giving albumin alongside large-volume drainage of abdominal fluid to head off the trigger before it starts.

The condition is far from rare: roughly a tenth of hospitalized ascites patients have it, and close to two in five people with cirrhosis and ascites will develop it within five years of diagnosis, with liver size, kidney-related hormone activity, and blood sodium levels marking out who is most at risk. Physicians noticed liver-linked kidney failure as far back as the late nineteenth century, but it took until the mid-twentieth century for researchers to link it clearly to abnormal circulation rather than direct kidney injury, partly through the striking finding that kidneys transplanted out of affected patients worked fine in new recipients. A formal definition only arrived in 1994 from a group of liver specialists, and understanding has kept evolving since, particularly around the chemical signals responsible for the vessel changes. Even today, some of the medical evidence rests on small or inconsistent studies, and questions remain about which treatments actually improve survival rather than just laboratory numbers.

Within five years of a cirrhosis diagnosis, 39% of patients develop hepatorenal syndrome — and short-term mortality in the rapidly progressive form exceeds 50%.

Read the whole of Hepatorenal syndrome on Wikipedia

The article comes from Wikipedia and is licensed under CC BY-SA 4.0. The introduction above is our own.